Dimensional Fund Advisors’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $273M | Sell |
|
|||||
|
2025
Q1 | $362M | Sell |
|
|||||
|
2024
Q4 | $418M | Buy |
|
|||||
|
2024
Q3 | $599M | Sell |
|
|||||
|
2024
Q2 | $616M | Sell |
|
|||||
|
2024
Q1 | $567M | Sell |
|
|||||
|
2023
Q4 | $521M | Sell |
|
|||||
|
2023
Q3 | $510M | Buy |
|
|||||
|
2023
Q2 | $440M | Sell |
|
|||||
|
2023
Q1 | $520M | Sell |
|
|||||
|
2022
Q4 | $458K | Sell |
|
|||||
|
2022
Q3 | $448M | Buy |
|
|||||
|
2022
Q2 | $374M | Buy |
|
|||||
|
2022
Q1 | $409M | Buy |
|
|||||
|
2021
Q4 | $317M | Buy |
|
|||||
|
2021
Q3 | $244M | Buy |
|
|||||
|
2021
Q2 | $179M | Buy |
|
|||||
|
2021
Q1 | $118M | Buy |
|
|||||
|
2020
Q4 | $114M | Buy |
|
|||||
|
2020
Q3 | $126M | Buy |
|
|||||
|
2020
Q2 | $135M | Buy |
|
|||||
|
2020
Q1 | $102M | Buy |
|
|||||
|
2019
Q4 | $77.6M | Sell |
|
|||||
|
2019
Q3 | $57.9M | Buy |
|
|||||
|
2019
Q2 | $61.5M | Buy |
|
|||||
|
2019
Q1 | $73.8M | Sell |
|
|||||
|
2018
Q4 | $68.5M | Buy |
|
|||||
|
2018
Q3 | $71.7M | Buy |
|
|||||
|
2018
Q2 | $59.3M | Buy |
|
|||||
|
2018
Q1 | $58.4M | Buy |
|
|||||
|
2017
Q4 | $63M | Buy |
|
|||||
|
2017
Q3 | $72.2M | Buy |
|
|||||
|
2017
Q2 | $79M | Buy |
|
|||||
|
2017
Q1 | $61.7M | Buy |
|
|||||
|
2016
Q4 | $57M | Sell |
|
|||||
|
2016
Q3 | $62.8M | Buy |
|
|||||
|
2016
Q2 | $49.4M | Buy |
|
|||||
|
2016
Q1 | $50.8M | Buy |
|
|||||
|
2015
Q4 | $74.1M | Buy |
|
|||||
|
2015
Q3 | $60.1M | Buy |
|
|||||
|
2015
Q2 | $64.9M | Buy |
|
|||||
|
2015
Q1 | $55.2M | Buy |
|
|||||
|
2014
Q4 | $49.7M | Buy |
|
|||||
|
2014
Q3 | $41.4M | Sell |
|
|||||
|
2014
Q2 | $36.5M | Buy |
|
|||||
|
2014
Q1 | $38.5M | Buy |
|
|||||
|
2013
Q4 | $35.1M | Sell |
|
|||||
|
2013
Q3 | $40M | Buy |
|
|||||
|
2013
Q2 | $28.5M | Buy |
|